Delivery Order SPE2DR25D6028-SPE2DR26FARSD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,759.00 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ml syringes. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Pediarix is a pediatric combination vaccine, and this order represents one of numerous pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $17,990.35 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ML syringes. This competitively awarded, firm fixed price contract was executed on September 25, 2025, with an ultimate completion date of September 26, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,276.61 on August 8, 2025, for the supply of Pediarix 0.5 ML syringes. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 11, 2025, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's broader contractual...
- The Defense Logistics Agency awarded a $8,259.00 delivery order to AmerisourceBergen Drug Corp for Pediarix 0.5 ML syringes on November 6, 2025, with completion scheduled for November 7, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The contract involves no set-aside designation and specifies...
- The Defense Department's Medical Supply Chain awarded a $30,524.62 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Pediarix 0.5mL syringes (10-count packages). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 1, 2025, and represents a child order under a larger contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Pediarix 0.5 ML syringes valued at $12,430.40 with a firm fixed price contract structure. This is a non-set-aside competitive award with an ultimate completion date of November 10, 2025, and performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $3,342.11 to AmerisourceBergen Drug Corp for Pediarix 0.5 ML syringes, with an ultimate completion date of September 19, 2025. This non-set-aside contract reflects firm fixed pricing and represents a competitive award to the pharmaceutical distributor. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Pediarix 0.5 ML syringes, a pediatric vaccine product. This competitively awarded, non-set-aside contract is valued at $6,988.75 with a firm fixed price and an ultimate completion date of September 4, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $5,331.52 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric vaccination product sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation and is executed under a larger indefinite...
- The Defense Logistics Agency awarded a $8,506 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes, with an ultimate completion date of August 18, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be performed from the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and a key...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARSDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,618.30 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Pediarix 0.5mL syringes (10-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vehicle through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company maintains an extensive portfolio of federal contract awards with the DLA Medical Supply Chain, consistently delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for pediatric vaccine formulations supports the company's role as a key supplier for military medical readiness and healthcare operations. The contract reflects AmerisourceBergen's demonstrated capability to fulfill federal procurement requirements through open competition and its position as a preferred vendor within the DLA's strategic pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 11/14/25 |